Frontier Capital Management CO LLC Cara Therapeutics, Inc. Transaction History

Frontier Capital Management CO LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 19, 2021	SELL	$11.55 - $16.06 $2.9 Million - $4.03 Million	-251,107 Closed	0 $0
Q2 2021 Aug 09, 2021	SELL	$12.38 - $29.19 $406,138 - $957,607	-32,806 Reduced 11.55%	251,107 $3.58 Million
Q1 2021 May 13, 2021	SELL	$15.07 - $21.71 $1.4 Million - $2.01 Million	-92,804 Reduced 24.63%	283,913 $6.16 Million
Q4 2020 Jan 19, 2021	BUY	$12.72 - $16.16 $1.44 Million - $1.83 Million	113,465 Added 43.1%	376,717 $5.7 Million
Q3 2020 Nov 16, 2020	BUY	$12.34 - $17.92 $3.25 Million - $4.72 Million	263,252 New	263,252 $3.35 Million

12.8M

Ticker CARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,725,900
Market Cap $22.6M
Description
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...

Get notified when there are updates to the investment portfolio of Frontier Capital Management CO LLC, based on Form 13F filings with the SEC.

Stay updated on Frontier Capital Management CO LLC with notifications on news.